8.26–8.39 (m, 4H), 8.40–8.64 (m, 2H) 13C NMR (CD3COCD3)
δ 124.1, 124.4, 127.9, 129.5, 130.7, 133.9, 135.2, 138.9, 148.1,
158.8, 165.9; HRMS (CIϩ) exact mass calcd. for C16H10N2O4
294.06406, found: 294.06151.
(CH), 129.2 (C), 132.3 (CH), 159.3 (C), 161.2 (C), 165.6 (C);
HRMS (Clϩ) exact mass calcd. for C15H15NO2 241.11028,
found 241.11014.
Acknowledgements
4-(4Ј-Chlorobenzylidene)-2-phenyloxazol-5(4H)-one (7). Mp
197 ЊC; νmax/cmϪ1 1796, 1655, 1590, 1555, 1490, 1162, 826, 695;
1H NMR (CD3COCD3) δ 7.17 (s, 1H), 7.44 (d, 2H, J = 8.3 Hz),
7.53–7.63 (m, 3H) 8.1–8.2 (m, 4H); 13C NMR (CD3COCD3)
δ 125.8 (C), 128.5 (CH), 129.0 (CH), 129.3 (CH), 129.9 (CH),
132.1 (C), 133.5 (CH), 133.7 (C), 137.3 (C), 164.1 (C), 167.2
(C); HRMS (CIϩ) exact mass calcd. for C16H10ClNO2
283.04001, found 283.03953.
The authors gratefully acknowledge the subsidies granted by
the Ministerio de Ciencia y Tecnologia, DGI (Projet BQU2001/
2605), and by the Consejería de Educación y Ciencia (Junta de
Andalucía), Spain. The valuable help of Prof. M. Sullivan in the
grammatical revision of the manuscript is also acknowledged.
References
4-(4Ј-Methoxybenzylidene)-2-phenyloxazol-5(4H)-one
(8).
1 (a) F. M. Bautista, J. M. Campelo, A. García, D. Luna and
J. M. Marinas, Amino Acids, 1992, 2, 87; (b) K. Gottwald and
D. Seebach, Tetrahedron, 1999, 55, 723; (c) J. Meiwes, M. Schudock
and G. Kretzschmar, Tetrahedron: Asymmetry, 1997, 8, 527; (d )
D. Seebach, G. Jaeschke, K. Gottwald, K. Matsuda, M. Breuning
and G. Bringmann, Tetrahedron, 1997, 22, 7359; (e) C. Cativela,
M. D. Diaz-de-Villegas, J. I. García and A. I. Jimenez, Tetrahedron,
1997, 53, 4479; ( f ) E. Buñuel, C. Cativela and M. D. Diaz-de-
Villegas, Tetrahedron, 1995, 32, 8923; (g) D. Donati, A. Garzon-
Aburbeh, B. Natalini, C. Marchioro and R. Pellicciari, Tetrahedron,
1996, 52, 9901.
Mp 157 ЊC; νmax/cmϪ1 1790, 1652, 1598, 1513, 1266, 1162, 1030,
1
830, 695; H NMR (CDCl3) δ 3.81 (s, 3H) 7.06–7.12 (m, 2H),
7.24 (s, 1H), 7.58–7.69 (m, 3H), 8.03–8.36 (m, 4H); 13C NMR
(CDCl3) δ 55.9 (CH3), 115.4 (CH), 126.6 (C), 127.5 (C) 128.8
(CH), 129.4 (C), 130.0 (CH), 132.0 (CH), 134.1 (CH), 135.2
(CH), 135.5 (CH), 156.8 (C), 163.3 (C), 167.6 (C); HRMS
(CIϩ) exact mass calcd. for C17H13NO2 279.08954, found
279.08937.
2 (a) F. Cavalier and J. Verducci, Tetrahedron Lett., 1995, 36, 4425;
(b) S. N. Mitra, S. Dey, S. Karthikeyan and T. P. Singh, Biopolymers,
1997, 41, 1997.
4-(3Ј,4Ј-Methylenedioxybenzylidene)-2-phenyloxazol-5(4H)-
one (9). Mp 195 ЊC; νmax/cmϪ1 1779, 1648, 1486, 1451, 1266,
1165, 926, 864, 698; 1H NMR (CD3COCD3) δ 6.17 (s, 2H) 7.02
(d, 1H, J = 8.0 Hz), 7.23 (s, 1H), 7.63–7.72 (m, 4H), 8.17–8.20
(m, 3H); 13C NMR (CD3COCD3) δ 103.1 (CH2), 109.5 (CH),
111.5 (CH), 126.7 (C) 128.8 (CH), 129.2 (C), 130.1 (CH), 130.4
(CH), 131.9 (CH), 132.3 (C), 134.2 (CH), 137.6 (C), 143.9 (C),
151.6 (C), 163.6 (C); HRMS (CIϩ) exact mass calcd. for
C17H11NO4 293.06881, found 293.06999.
3 (a) A. P. Martinez, W. W. Lee and L. Goodman, Tetrahedron, 1964,
20, 2763; (b) M. L. Gelmi, F. Clerici and A. Melis, Tetrahedron,
1997, 53, 1843; (c) A. H. Abd-el-Rahm, E. M. Kandeel,
E. A. Abdel-Razik and I. A. El-Ghamry, An. Quím., 1993, 89, 237.
4 (a) P. D. Croce, R. Ferraccioli and C. La-Rosa, J. Chem. Soc., Perkin
Trans. 1, 1994, 2499; (b) R. Cannella, F. Clerici, M. L. Gelmi,
M. Penso and D. Pocar, J. Org. Chem., 1996, 61, 1854; (c) R. Bossio,
S. Marcaccini, R. Pepino and P. Paoli, J. Heterocycl. Chem.,
1994, 31, 729; (d ) I. Arenal, M. Bernabe, E. Fernandez-Alvarez,
M. L. Izquierdo and S. Penades, J. Heterocycl. Chem., 1983, 20, 607.
5 (a) A. C. Chikere, B. Galunsky, V. Schünemann and V. Kasche,
Enzyme Microb. Technol., 2001, 28, 168; (b) J. Penalba, R. Puchades,
A. Maquieira, S. Gee and B. D. Hammock, Biosens. Bioelectron.,
2000, 15, 99; (c) M. A. Gonzalez-Martinez, R. Puchades, A.
Maquieira, I. Ferrer, M. P. Marco and D. Barceló, Anal. Chim. Acta,
1999, 386, 201; (d ) S. Kojima, H. Ohkawa, T. Hirano, S. Maki,
H. Niwa, M. Ohashi, S. Inouye and F. I. Tsuji, Tetrahedron
Lett., 1998, 39, 5242; (e) G. T. Hermanson, G. R. Mattson and
R. I. Krohn, J. Chromatogr. A, 1995, 691, 113.
6 (a) R. Filler, Advances in Heterocyclic Chemistry, ed. A. R. Katrizky,
Academic Press, New York, 1954, ch. 4, p. 75; (b) J. W. Cornforth
Chemistry of Penicillin, eds. J. R. Johnson and R. Robinson,
Princeton University Press, Princeton, New York, 1948, p. 688;
(c) H. E. Carter, Organic Reactions, Wiley, New York, 1946, ch. 3,
p. 198; (d ) S. P. Dhoubhadel, J. Indian Chem. Soc., 1986, 63,
757; (e) M. Kitazawa, R. Higuchi, M. Takahashi, T. Wada and
H. Sasabe, J. Phys. Chem., 1995, 99, 14784; ( f ) S. Icli, H. Icil, S. Alp,
H. Koc and A. McKillop, Spectrosc. Lett., 1994, 27, 1115;
(g) A. Patra, G. Ghosh and P. K. Mukhopadhyay, J. Indian Chem.
Soc., 1987, 64, 414.
7 (a) Y. S. Rao and R. Filler, Synthesis, 1975, 749; (b) I. Arenal,
M. Bernabe and E. Fernandez-Alvarez, An. Quím., 1981, 77, 56;
(c) G. V. Boyd and P. H. Wright, J. Chem. Soc., Perkin Trans. 1, 1972,
909; (d ) Y. S. Rao, J. Org. Chem., 1976, 41, 722.
8 (a) E. Galantay, A. Szabo and J. Fried, J. Org. Chem., 1963, 28,
98; (b) T. Wieland and V. Georgi, Liebigs Ann. Chem., 1966,
700, 133; (c) C. Cativiela and E. Melendez, Synthesis, 1978, 832;
(d ) C. Cativela, M. D. Diaz-de-Villegas and J. A. Galvez,
Tetrahedron Lett., 1999, 40, 1027.
9 P. S. Rao and R. V. Venkatratnam, Indian J. Chem., Sect. B, 1994, 33,
984.
10 M. Kidwai, R. Kumar and P. Kumar, Indian J. Chem., Sect. B, 1996,
35, 1004.
4-(3Ј-Phenylpropenylidene)-2-phenyloxazol-5(4H)-one (10).
Mp 151 ЊC; νmax/cmϪ1 1787, 1640, 1598, 1451, 1331, 1162, 872,
1
695; H NMR (CD3COCD3) δ 7.18 (s, 1H) 7.21 (S, 1H), 7.31–
7.49 (m, 4H), 7.59–7.72 (m, 4H), 8.03–8.16 (m, 3H); 13C NMR
(CD3COCD3) δ 123.9 (CH), 124.1 (CH), 126.7 (CH), 127.9 (C)
128.6 (CH), 128.8 (CH), 129.8 (CH), 130.0 (CH), 130.8 (CH),
133.1 (CH), 133.9 (CH), 134.3 (CH), 135.1 (C), 137.1 (C), 138.1
(CH), 144.7 (CH), 145.7 (CH), 162.9 (C), 165.7 (C); HRMS
(CIϩ) exact mass calcd. for C17H13NO2 275.09463, found
275.09470.
4-(1Ј-Methyl-3Ј-Phenylpropenylidene)-2-phenyloxazol-
5(4H)-one (11). Mp 155 ЊC; νmax/cmϪ1 1779, 1632, 1559, 1447,
1
1173, 965, 880, 695; H NMR (CD3COCD3) δ 4.15 (d, 3H,
J = 6.3 Hz), 7.47–7.53 (m, 7H), 7.93–8.13 (m, 5H); 13C NMR
(CD3COCD3) δ 41.8 (CH3), 127.0 (C), 128.1 (CH), 128.4 (CH)
128.6 (CH), 129.0 (CH), 129.3 (CH), 129.9 (CH), 130.4 (C),
132.2 (CH), 132.5 (CH), 133.6 (C), 134.2 (C), 135.3 (CH), 139.2
(CH), 167.7 (C), 171.4 (C); HRMS (CIϩ) exact mass calcd. for
C19H15NO2 289.11028 found 289.10999.
4-(But-2Ј-enylidene)-2-phenyloxazol-5(4H)-one (12). Mp 154
ЊC; νmax/cmϪ1 1791, 1655, 1559, 1451, 1327, 1181, 860, 698;
1H NMR (CD3COCD3) δ 1.94 (m, 3H) 6.63 (m, 1H), 6.98 (m,
2H), 7.55–7.63 (m, 2H), 7.66–7.70 (m, 1H), 8.07–8.11 (m, 2H);
13C NMR (CD3COCD3) δ 19.5 (CH3), 126.8 (C), 127.9 (C),
128.0 (CH) 128.6 (CH), 130.0 (CH), 133.5 (CH), 133.9 (CH),
145.2 (CH), 162.6 (C), 167.2 (C); HRMS (CIϩ) exact mass
calcd. for C13H11NO2 213.07898, found 213.07921.
11 (a) J. H. Clark and D. J. Macquarrie, Chem. Soc. Rev., 1996, 303;
(b) Supported Reagents and Catalysts in Chemistry, eds. B. K.
Hodnett, A. P. Kybett, J. H. Clark and K. Smith, Royal Society
of Chemistry, Cambridge, UK, 1998; (c) G. W. Kabalka and
R. M. Pagni, Tetrahedron, 1997, 53, 7999; (d ) J. M. Fraile,
J. I. García and J. A. Mayoral, Catal. Today, 2000, 57, 3; (e) F. A. H.
Al-Qallaf, R. A. W. Johnstone, J.-Y. Liu and D. Whittaker, J. Chem.
Soc., Perkin Trans. 2, 1999, 1421.
4-Cyclohexylidene-2-phenyloxazol-5(4H)-one (13). Mp 128
ЊC; νmax/cmϪ 2938, 2863, 1779, 1659, 1450, 1293, 1170, 979,
885, 704, H NMR (CD3COCD3) δ 1.68–1.81 (m, 6H), 2.83
(t, 2H, J = 6.1 H), 3.02 (t, 2H, J = 5.9 Hz), 7.26–7.54 (m, 3H),
8.01–8.06 (m, 2H); 13C NMR (CD3COCD3) δ 28.2 (CH2), 28.3
(CH2, 29.1 (CH2), 32.1 (CH2), 126.4 (C), 127.7 (CH), 128.8
1
J. Chem. Soc., Perkin Trans. 2, 2002, 227–234
233